SCHEMBL3639206

SCHEMBL3639206

CC(N)C(Cc1ccccc1)NCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 5/20 0.61
▸ CYP2D6 P10635 1/20 0.55
▸ TAAR1 Q96RJ0 4/20 0.53
▸ SLC6A2 P23975 2/20 0.53
▸ MAOA P21397 1/20 0.53
▸ SLC6A4 P31645 1/20 0.53
▸ SLC6A3 Q01959 1/20 0.53
▸ CYP2A6 P11509 1/20 0.53
▸ ADORA2A P29274 1/20 0.53
▸ ADORA1 P30542 1/20 0.53
▸ EPHX1 P07099 1/20 0.47
▸ SLC18A2 Q05940 1/20 0.46
▸ BCHE P06276 1/20 0.45
▸ POLB P06746 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4744231 0.85 SIGMAR1 (0.61) SIGMAR1CYP2D6TAAR1SLC6A2MAOA
SCHEMBL4091905 0.85 TAAR1 (0.59) SIGMAR1CYP2D6TAAR1SLC6A2MAOA
SCHEMBL23387949 0.81 CYP2D6 (0.50) SIGMAR1CYP2D6TAAR1SLC6A2MAOA
SCHEMBL2499040 0.78 SIGMAR1 (0.61) SIGMAR1CYP2D6TAAR1SLC6A2MAOA
SCHEMBL18032935 0.76 SIGMAR1 (0.59) SIGMAR1CYP2D6TAAR1SLC6A2MAOA
N-Benzylamphetamine SCHEMBL2795222 0.76 SIGMAR1 (1.00) SIGMAR1CYP2D6TAAR1SLC18A2POLB
N-Benzylamphetamine SCHEMBL2798189 0.76 SIGMAR1 (1.00) SIGMAR1CYP2D6TAAR1SLC18A2POLB
N-Benzylamphetamine SCHEMBL2451256 0.76 SIGMAR1 (1.00) SIGMAR1CYP2D6TAAR1SLC18A2POLB
SCHEMBL6447512 0.76 BCHE (0.48) SIGMAR1TAAR1SLC6A2MAOASLC6A4
Hydrochloric Acid SCHEMBL6446345 0.75 BCHE (0.47) SIGMAR1EPHX1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback